Strategic Pharmaceutical Partnerships Lead
Chris joined Medavie Blue Cross in 2015, with 25 years of experience as a senior leader within the research-based pharmaceutical industry in Canada. With the majority of his career focussed on External Affairs, including strategy and relationship development with governments, private payers & other health stakeholders across Canada, Chris has developed expertise in drug pricing, access, negotiation and patient health management strategies. He has played a lead role in development and implementation of numerous disease [drug] management partnership programs, impacting both public and private health system outcomes.
Check out Chris's posts
Drug Plan Trends Report: A snapshot of what’s coming down the pike
Medavie Blue Cross has also seen a significant decline in new patient starts for hepatitis C medications, says Chris Goguen, the insurer’s strategic pharmaceutical partnerships lead in Moncton, N.B. Demand is now one-fifth of the volume it was a...
The pace of change in the drug landscape is applying unprecedented cost and complexity pressures on private benefit plans in Canada. So how can plan sponsors manage drug costs effectively and sustainably in this fast-moving, ever-changing...